Tag: Vaccines
Exercise May Boost Immune Response to Flu Vaccine
However, acute exercise does not show benefit for generally inactive people
Veterans Report Low Rates of Adverse Events With mRNA Vaccines
Rates slightly higher at 42 days for those receiving Pfizer versus Moderna
COVID-19 Vaccines Cut Mortality With Heart Failure
Those who are partially vaccinated and unvaccinated face same increased risk, while boosted and fully vaccinated adults fare best
FDA Advisors Back Moderna Shot for Older Children, Teens
Some panel members noted that the vaccine would likely help prevent serious illness but not be as good at blocking mild infections
Relative Risk for CVT Up After AZD1222 COVID-19 Vaccine
Relative rates of hospital contacts for coagulation disorder, cerebrovascular disease increased after AZD1222 vaccination
Vaccine Effectiveness Against SARS-CoV-2 Infection Wanes Over Time
However, for all ages, vaccine effectiveness against severe COVID-19 high overall at 90 percent five months or longer after two doses
FDA Panel to Weigh Moderna Vaccine for Those Aged 6 to 17
Regulators have been concerned about reports of myocarditis seen mostly in young men receiving the Moderna vaccine
Text Messaging Intervention Does Not Improve COVID-19 Vaccine Uptake
No increase in vaccine uptake seen for individuals receiving text message versus phone calls or for behaviorally informed message content
Pfizer, Moderna COVID-19 Shots Work for Children Under 5, FDA Says
On Wednesday, advisory panel will weigh whether the FDA should authorize the use of both the Pfizer and Moderna vaccines for young children
Durability of mRNA-1273 Protection Against Symptomatic COVID-19 Examined
Among those receiving two doses, peak vaccine efficacy against symptomatic COVID-19 estimated to be 94.1 percent at 120 days after first dose
